Furthermore, genetic variants, reduced protein levels, and diminished catalytic activity of CTSB and CTSL have been associated with neuropathology, including Parkinson’s disease [31, 36, 37], highlighting the essential role of both proteases in maintaining neuronal health. This evidence concerns the gene CTSL and Parkinson disease.